As of 2025-10-23, the EV/EBITDA ratio of KemPharm Inc (KMPH) is -6.44. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KMPH's latest enterprise value is 153.95 mil USD. KMPH's TTM EBITDA according to its financial statements is -23.90 mil USD. Dividing these 2 quantities gives us the above KMPH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.1x - 8.8x | 6.2x |
| Forward P/E multiples | 7.7x - 12.9x | 9.9x |
| Fair Price | (4.00) - (4.76) | (4.24) |
| Upside | -168.8% - -181.9% | -173.1% |
| Date | EV/EBITDA |